🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to test a new drug called MK-2206. This study ...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2010-07
Trial ID
NCT01169649
Treatments Being Tested
This phase I trial studies the side effects and the best dose of Akt inhibi...
Status
Active Not Recruiting
Location
Rutgers Cancer Institute of New Jersey
Start Date
2011-11-23
Trial ID
NCT01480154
Treatments Being Tested
Background: \- The current standard of care for advanced lung cancer and c...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2011-02-08
Trial ID
NCT01306045
This phase II clinical trial studies how well Akt inhibitor MK2206 works in...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2010-12
Trial ID
NCT01258998
Treatments Being Tested
This phase II trial is studying how well AKT inhibitor MK-2206 works in tre...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2010-10
Trial ID
NCT01253447
Treatments Being Tested
A significant number of all invasive breast cancers are hormone sensitive a...
Status
Withdrawn
Location
Mallinckrodt Institute of Radiology
Start Date
2013-06
Trial ID
NCT01714128
Treatments Being Tested
This phase II trial is studies how well Akt inhibitor MK2206 works in treat...
Status
Terminated
Location
Columbia University Medical Center
Start Date
2011-04
Trial ID
NCT01319539
This phase II trial studies how well Akt inhibitor MK2206 works in treating...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2011-03
Trial ID
NCT01277757
Treatments Being Tested
This phase II clinical trial studies how well Akt inhibitor MK2206 works in...
Status
Completed
Location
Providence Hospital
Start Date
2011-01
Trial ID
NCT01260701
Treatments Being Tested
The purpose of this study is to evaluate the antitumor efficacy and the saf...
Status
Terminated
Location
Institut Bergonié
Start Date
2011-11
Trial ID
NCT01466868
Treatments Being Tested